Database of adverse events associated with drugs and drug combinations

被引:15
|
作者
Poleksic, Aleksandar [1 ]
Xie, Lei [2 ,3 ]
机构
[1] Univ Northern Iowa, Dept Comp Sci, Cedar Falls, IA 50614 USA
[2] CUNY Hunter Coll, Dept Comp Sci, New York, NY 10065 USA
[3] CUNY, Grad Ctr, PhD Comp Sci Program, New York, NY 10065 USA
关键词
TRANSPLANT RECIPIENT; CYCLOSPORINE; BOSENTAN; SAFETY; ETOPOSIDE; SIROLIMUS; WARFARIN;
D O I
10.1038/s41598-019-56525-5
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Due to the aging world population and increasing trend in clinical practice to treat patients with multiple drugs, adverse events (AEs) are becoming a major challenge in drug discovery and public health. In particular, identifying AEs caused by drug combinations remains a challenging task. Clinical trials typically focus on individual drugs rather than drug combinations and animal models are unreliable. An added difficulty is the combinatorial explosion in the number of possible combinations that can be made using the increasingly large set of FDA approved chemicals. We present a statistical and computational technique for identifying AEs caused by two-drug combinations. Taking advantage of the large and increasing data deposited in FDA's postmarketing reports, we demonstrate that the task of predicting AEs for 2-drug combinations is amenable to the Likelihood Ratio Test (LRT). Our pAERS database constructed with LRT contains almost 77 thousand associations between pairs of drugs and corresponding AEs caused solely by drug-drug interactions (DDIs). The DDIs stored in pAERS complement the existing data sets. Due to our stringent statistical test, we expect many of the associations in pAERS to be unrecorded or poorly documented in the literature.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy
    Akio Negishi
    Shinji Oshima
    Norimitsu Horii
    Mizue Mutoh
    Naoko Inoue
    Sachihiko Numajiri
    Shigeru Ohshima
    Daisuke Kobayashi
    [J]. Drugs - Real World Outcomes, 2021, 8 : 49 - 61
  • [22] Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy
    Negishi, Akio
    Oshima, Shinji
    Horii, Norimitsu
    Mutoh, Mizue
    Inoue, Naoko
    Numajiri, Sachihiko
    Ohshima, Shigeru
    Kobayashi, Daisuke
    [J]. DRUGS-REAL WORLD OUTCOMES, 2021, 8 (01) : 49 - 61
  • [23] Anticoagulation-Associated Adverse Drug Events
    Piazza, Gregory
    Nguyen, Thanh N.
    Cios, Deborah
    Labreche, Matthew
    Hohlfelder, Benjamin
    Fanikos, John
    Fiumara, Karen
    Goldhaber, Samuel Z.
    [J]. CIRCULATION, 2011, 124 (21)
  • [24] Anticoagulation-associated Adverse Drug Events
    Piazza, Gregory
    Thanh Nha Nguyen
    Cios, Deborah
    Labreche, Matthew
    Hohlfelder, Benjamin
    Fanikos, John
    Fiumara, Karen
    Goldhaber, Samuel Z.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2011, 124 (12): : 1136 - 1142
  • [25] Adverse drug events associated with hospital admission
    Peyriere, H
    Cassan, S
    Floutard, E
    Riviere, S
    Blayac, JP
    Hillaire-Buys, D
    Le Quellec, A
    Hansel, S
    [J]. ANNALS OF PHARMACOTHERAPY, 2003, 37 (01) : 5 - 11
  • [26] Adverse drug events associated with disorders of coagulation
    Barletta, Jeffrey F.
    Cooper, Brad
    Ohlinger, Martin J.
    [J]. CRITICAL CARE MEDICINE, 2010, 38 : S198 - S218
  • [27] Adverse hepatic events associated with drug therapy
    Hewitt, J
    Hammond, L
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1996, 165 (06) : 347 - 350
  • [28] Adverse drug events associated with ethanol and fomepizole
    Lepik, K.
    Levy, A.
    Sobolev, B.
    Purssell, R.
    DeWitt, C.
    Erhardt, G.
    Kennedy, J.
    Daws, D.
    Brignall, J.
    [J]. CLINICAL TOXICOLOGY, 2007, 45 (06): : 648 - 648
  • [29] Use of a spontaneous adverse drug events database for identification of unanticipated drug benefits
    Brinker, A
    Beitz, J
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (01) : 99 - 102
  • [30] Drugs Associated with Ineffectiveness as Adverse Drug Reaction
    S. Borgsteede
    E. Van Puijenbroek
    A. Passier
    K. Van Grootheest
    [J]. Drug Safety, 2008, 31 : 885 - 885